ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000260743.1	Cytarabine	Bladder urothelial carcinoma	0.008047829	Sensitive
ENSG00000260743.1	Cytarabine	Pancreatic adenocarcinoma	0.012434665	Sensitive